Literature DB >> 3257103

Alterations in binding characteristics of the human immunodeficiency virus enhancer factor.

F Wu1, J Garcia, R Mitsuyasu, R Gaynor.   

Abstract

Five regions of the human immunodeficiency virus (HIV) long terminal repeat (LTR) serve as binding sites for cellular proteins as demonstrated by DNase I footprinting. These include the negative regulatory, enhancer, SP1, TATA, and untranslated regions. The HIV enhancer region contains two direct repeats of a sequence, GGGACTTTCC, which is also found in the enhancer sequences of simian virus 40, cytomegalovirus, and the immunoglobulin kappa gene. To further characterize binding to the enhancer sequences in the HIV LTR, DNase I footprinting was performed using extracts prepared from several different cell lines. Extracts prepared from lymphoid cells gave altered binding over the enhancer region as compared with extracts prepared from either monocytes or HeLa cells. This altered binding in extracts prepared from lymphoid cells resulted in protection of both direct repeats in the HIV LTR in contrast to complete protection of only one direct repeat with HeLa cell extracts. When HeLa cells were treated with phorbol esters in either the presence or absence of the protein synthesis inhibitor cycloheximide, the binding characteristics over the enhancer element became similar to those seen in extracts prepared from lymphoid cells. These results suggest that phorbol esters may induce posttranslational modifications of cellular transcription factors that alter their DNA-binding characteristics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257103      PMCID: PMC250522     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.

Authors:  H Singh; R Sen; D Baltimore; P A Sharp
Journal:  Nature       Date:  1986 Jan 9-15       Impact factor: 49.962

2.  The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.

Authors:  C A Rosen; J G Sodroski; W A Haseltine
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

3.  An immunoglobulin promoter displays cell-type specificity independently of the enhancer.

Authors:  J Foster; J Stafford; C Queen
Journal:  Nature       Date:  1985 May 30-Jun 5       Impact factor: 49.962

4.  Direct activation of resting T lymphocytes by human T-lymphotropic virus type I.

Authors:  L Gazzolo; M Duc Dodon
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

5.  Duplications of a mutated simian virus 40 enhancer restore its activity.

Authors:  W Herr; Y Gluzman
Journal:  Nature       Date:  1985 Feb 21-27       Impact factor: 49.962

6.  Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.

Authors:  J S McDougal; M S Kennedy; J M Sligh; S P Cort; A Mawle; J K Nicholson
Journal:  Science       Date:  1986-01-24       Impact factor: 47.728

7.  Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

Authors:  K A Jones; J T Kadonaga; P A Luciw; R Tjian
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

8.  AIDS-associated retroviruses (ARV) can productively infect other cells besides human T helper cells.

Authors:  J A Levy; J Shimabukuro; T McHugh; C Casavant; D Stites; L Oshiro
Journal:  Virology       Date:  1985-12       Impact factor: 3.616

9.  Cell-type preference of immunoglobulin kappa and lambda gene promoters.

Authors:  D Picard; W Schaffner
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

10.  Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells.

Authors:  L F Lau; D Nathans
Journal:  EMBO J       Date:  1985-12-01       Impact factor: 11.598

View more
  36 in total

1.  Probing protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1 by in vivo footprinting.

Authors:  F Demarchi; P D'Agaro; A Falaschi; M Giacca
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat.

Authors:  S L Zeichner; J Y Kim; J C Alwine
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.

Authors:  D Harrich; J Garcia; F Wu; R Mitsuyasu; J Gonazalez; R Gaynor
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Comparison of the transcriptional activity of the long terminal repeats of simian immunodeficiency viruses SIVmac251 and SIVmac239 in T-cell lines and macrophage cell lines.

Authors:  M G Anderson; J E Clements
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

5.  Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region.

Authors:  R Gaynor; E Soultanakis; M Kuwabara; J Garcia; D S Sigman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

6.  NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificity.

Authors:  M J Lenardo; A Kuang; A Gifford; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins.

Authors:  E Böhnlein; M Siekevitz; D W Ballard; J W Lowenthal; L Rimsky; H Bogérd; J Hoffman; Y Wano; B R Franza; W C Greene
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

8.  Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.

Authors:  G Feuer; M Taketo; R C Hanecak; H Fan
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage.

Authors:  H L Ross; M R Nonnemacher; T H Hogan; S J Quiterio; A Henderson; J J McAllister; F C Krebs; B Wigdahl
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.